Studies from Wuyi University Yield New Data on Ranitidine Therapy (Development, Optimization, and In Vitro/in Vivo Evaluation of Ranitidine Hydrochloride- Resinate Sustained-release Suspension).

Předmět:	RANITIDINE GASTROINTESTINAL agents DRUG therapy ION exchange resins ACCELERATED life testing
Zdroj:	Drug Week; 6/2/2023, p2116-2116, 1p
Abstrakt:	Keywords: Jiangmen; People's Republic of China; Asia; Drugs and Therapies; Gastrointestinal Agents; H2 Antagonists; Health and Medicine; Pharmaceuticals; Ranitidine Therapy EN Jiangmen People's Republic of China Asia Drugs and Therapies Gastrointestinal Agents H2 Antagonists Health and Medicine Pharmaceuticals Ranitidine Therapy 2116 2116 1 05/29/23 20230602 NES 230602 2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Drugs and Therapies - Ranitidine Therapy have been published. Accelerated stability test results showed that the optimized RH suspension exhibited good stability over a period of 6 months (F > 0.9; drug content: 97 - 100 %, drug release: f2 > 50; drug leakage < 0.5 %), with good redispersibility. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu